{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:55Z","timestamp":1792607875986,"version":"4.5.0"},"reference-count":85,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1193,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1600-0404.2012.01684.x","type":"journal-article","created":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T06:33:15Z","timestamp":1338013995000},"page":"219-228","source":"Crossref","is-referenced-by-count":33,"title":["Vigabatrin-associated retinal damage - potential biochemical mechanisms"],"prefix":"10.1155","volume":"126","author":[{"given":"M. K.","family":"Heim","sequence":"first","affiliation":[{"name":"School of Pharmacy; University of Wisconsin - Madison; Madison; WI; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. E.","family":"Gidal","sequence":"additional","affiliation":[{"name":"School of Pharmacy & Department of Neurology; University of Wisconsin - Madison; Madison; WI; USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,26]]},"reference":[{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0001|ane1684-cit-0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0002|ane1684-cit-0002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1528-1157.1993.tb02126.x","article-title":"Some aspects of prognosis in the epilepsies: a review","volume":"34","author":"Sander","year":"1993","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0003|ane1684-cit-0003","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0004|ane1684-cit-0004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.yebeh.2006.03.010","article-title":"Intractable epilepsy: a survey of patients and caregivers","volume":"8","author":"Wheless","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0005|ane1684-cit-0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199141060-00007","article-title":"Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control","volume":"41","author":"Grant","year":"1991","journal-title":"Drugs"},{"issue":"Suppl 192","key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0006|ane1684-cit-0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0404.2011.01596.x","article-title":"Mechanism of action of vigabatrin: correcting misperceptions","volume":"124","author":"Ben-Menachem","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0007|ane1684-cit-0007","volume-title":"Sabril full prescribing information","year":"2009"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0008|ane1684-cit-0008","first-page":"CD007302","article-title":"Vigabatrin for refractory partial epilepsy","author":"Hemming","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"11 Suppl 5","key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0009|ane1684-cit-0009","first-page":"S21","article-title":"The role of vigabatrin in the management of infantile epileptic syndromes","volume":"43","author":"Appleton","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0010|ane1684-cit-0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1528-1157.1996.tb00573.x","article-title":"Long-term outcome of West syndrome: a study of adults with a history of infantile spasms","volume":"37","author":"Riikonen","year":"1996","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0011|ane1684-cit-0011","first-page":"CD001770","article-title":"Treatment of infantile spasms","author":"Hancock","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 192","key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0012|ane1684-cit-0012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0404.2011.01599.x","article-title":"Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing","volume":"124","author":"Carmant","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0013|ane1684-cit-0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","article-title":"Severe persistent visual field constriction associated with vigabatrin","volume":"314","author":"Eke","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0014|ane1684-cit-0014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eplepsyres.2010.09.004","article-title":"Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy","volume":"92","author":"Sergott","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0015|ane1684-cit-0015","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","article-title":"Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review","volume":"51","author":"Maguire","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0016|ane1684-cit-0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eplepsyres.2006.03.012","article-title":"A pharmacogenetic exploration of vigabatrin-induced visual field constriction","volume":"70","author":"Kinirons","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0017|ane1684-cit-0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 update","volume":"50","author":"Willmore","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0018|ane1684-cit-0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/NDT.S5236","article-title":"Treatment of refractory complex partial seizures: role of vigabatrin","volume":"5","author":"Waterhouse","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0019|ane1684-cit-0019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0020|ane1684-cit-0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.2000.tb00134.x","article-title":"The potential for vigabatrin-induced intramyelinic edema in humans","volume":"41","author":"Cohen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0021|ane1684-cit-0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2011.07.030","article-title":"Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA","volume":"72","author":"Herrmann","year":"2011","journal-title":"Neuron"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0022|ane1684-cit-0022","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ophtha.2004.03.036","article-title":"Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children","volume":"111","author":"Buncic","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0023|ane1684-cit-0023","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1167\/iovs.05-0854","article-title":"Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer","volume":"47","author":"Wild","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0024|ane1684-cit-0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.55.1.40","article-title":"Visual function loss from vigabatrin: effect of stopping the drug","volume":"55","author":"Johnson","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0025|ane1684-cit-0025","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","article-title":"Outer retinal dysfunction in patients treated with vigabatrin","volume":"52","author":"Arndt","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0026|ane1684-cit-0026","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","article-title":"Visual field defects associated with vigabatrin therapy","volume":"67","author":"Lawden","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0027|ane1684-cit-0027","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.22266","article-title":"Retinal nerve fiber layer thickness in vigabatrin-exposed patients","volume":"69","author":"Clayton","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0028|ane1684-cit-0028","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1755-3768.2010.02077.x","article-title":"Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity","volume":"89","author":"Moseng","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0029|ane1684-cit-0029","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2008.06175.x","article-title":"Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina","volume":"27","author":"Wang","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0030|ane1684-cit-0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20081","article-title":"Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats","volume":"55","author":"Duboc","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0031|ane1684-cit-0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00143216","article-title":"Possible role of amacrine cells in the generation of the mammalian ERG b-wave","volume":"61","author":"Gottlob","year":"1985","journal-title":"Doc Ophthalmol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0032|ane1684-cit-0032","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S0952523899163119","article-title":"Contribution of rod, on-bipolar, and horizontal cell light responses to the ERG of dogfish retina","volume":"16","author":"Shiells","year":"1999","journal-title":"Vis Neurosci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0033|ane1684-cit-0033","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1167\/iovs.07-1197","article-title":"Relationship of the optical coherence tomography signal to underlying retinal histology in the tree shrew (Tupaia belangeri)","volume":"50","author":"Abbott","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0034|ane1684-cit-0034","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","article-title":"Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings","volume":"50","author":"Krauss","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0035|ane1684-cit-0035","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","article-title":"Symptomatic and asymptomatic visual loss in patients taking vigabatrin","volume":"106","author":"Daneshvar","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0036|ane1684-cit-0036","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.WNL.0000098938.80082.25","article-title":"Peripheral retinal dysfunction in patients taking vigabatrin","volume":"61","author":"McDonagh","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0037|ane1684-cit-0037","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.visres.2006.12.014","article-title":"Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures","volume":"47","author":"Lascaratos","year":"2007","journal-title":"Vision Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0038|ane1684-cit-0038","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.0013-9580.2004.01004.x","article-title":"Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA","volume":"45","author":"Izumi","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0039|ane1684-cit-0039","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.21526","article-title":"Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity","volume":"65","author":"Jammoul","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0040|ane1684-cit-0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1475-1313.2002.00063.x","article-title":"Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance","volume":"22","author":"Hosking","year":"2002","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0041|ane1684-cit-0041","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3565(25)24999-0","article-title":"In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain","volume":"238","author":"Cubells","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0042|ane1684-cit-0042","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.57.2.196","article-title":"Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina","volume":"57","author":"Sills","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0043|ane1684-cit-0043","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1528-1157.2003.04203.x","article-title":"Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina","volume":"44","author":"Sills","year":"2003","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0044|ane1684-cit-0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(89)90368-6","article-title":"Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina","volume":"98","author":"Neal","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0045|ane1684-cit-0045","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.7638623","article-title":"Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors","volume":"269","author":"Staley","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0046|ane1684-cit-0046","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","article-title":"Molecular and cellular mechanisms of excitotoxic neuronal death","volume":"15","author":"Wang","year":"2010","journal-title":"Apoptosis"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0047|ane1684-cit-0047","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/mol.53.3.564","article-title":"Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl- and inhibitory transmitters","volume":"53","author":"Chen","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0048|ane1684-cit-0048","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.1999.7179","article-title":"Excitotoxic cell death dependent on inhibitory receptor activation","volume":"160","author":"Chen","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0049|ane1684-cit-0049","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.visres.2005.03.020","article-title":"Depolarizing effect of GABA in rod bipolar cells of the mouse retina","volume":"45","author":"Varela","year":"2005","journal-title":"Vision Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0050|ane1684-cit-0050","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1471-4159.1989.tb08559.x","article-title":"Excitatory amino acid-induced toxicity in chick retina: amino acid release, histology, and effects of chloride channel blockers","volume":"53","author":"Zeevalk","year":"1989","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0051|ane1684-cit-0051","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.74.3.339","article-title":"A controlled study comparing visual function in patients treated with vigabatrin and tiagabine","volume":"74","author":"Krauss","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0052|ane1684-cit-0052","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1212\/WNL.53.7.1518","article-title":"The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism","volume":"53","author":"Spanaki","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0053|ane1684-cit-0053","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bjo.87.1.96","article-title":"Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow","volume":"87","author":"Hosking","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0054|ane1684-cit-0054","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2010.08.006","article-title":"Is reduced ornithine-delta-aminotransferase activity the cause of vigabatrin-associated visual field defects?","volume":"92","author":"Sorri","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0055|ane1684-cit-0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00971857","article-title":"Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain","volume":"13","author":"Daune","year":"1988","journal-title":"Neurochem Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0056|ane1684-cit-0056","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1528-1157.1995.tb01618.x","article-title":"Reduction of plasma alanine aminotransferase during vigabatrin treatment","volume":"36","author":"Foletti","year":"1995","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0057|ane1684-cit-0057","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mcn.2010.01.008","article-title":"Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats","volume":"43","author":"Jammoul","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0058|ane1684-cit-0058","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1152\/physrev.1968.48.2.424","article-title":"Biochemistry and physiology of taurine and taurine derivatives","volume":"48","author":"Jacobsen","year":"1968","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0059|ane1684-cit-0059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-0173(91)90003-Q","article-title":"Taurine: retinal function","volume":"16","author":"Lombardini","year":"1991","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0060|ane1684-cit-0060","first-page":"1940","article-title":"Taurine suppresses the spread of cell death in electrically coupled RPE cells","volume":"14","author":"Udawatte","year":"2008","journal-title":"Mol Vis"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0061|ane1684-cit-0061","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1471-4159.1976.tb01519.x","article-title":"The distribution of taurine in the vertebrate retina","volume":"26","author":"Orr","year":"1976","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0062|ane1684-cit-0062","first-page":"53","article-title":"Dietary taurine is necessary for normal retinal development in monkeys","volume":"179","author":"Neuringer","year":"1985","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0063|ane1684-cit-0063","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0896-6273(04)00141-2","article-title":"A role for ligand-gated ion channels in rod photoreceptor development","volume":"41","author":"Young","year":"2004","journal-title":"Neuron"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0064|ane1684-cit-0064","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:NERE.0000010435.06586.e2","article-title":"Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies","volume":"29","author":"Massieu","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0065|ane1684-cit-0065","first-page":"CD006072","article-title":"Effect of taurine supplementation on growth and development in preterm or low birth weight infants","author":"Verner","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0066|ane1684-cit-0066","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.etp.2004.08.004","article-title":"Protective effect of taurine against free radicals damage in the rat myocardium","volume":"56","author":"Hanna","year":"2004","journal-title":"Exp Toxicol Pathol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0067|ane1684-cit-0067","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00726-003-0004-1","article-title":"Characteristics of taurine release induced by free radicals in mouse hippocampal slices","volume":"26","author":"Saransaari","year":"2004","journal-title":"Amino Acids"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0068|ane1684-cit-0068","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10284150290018991","article-title":"Taurine: evidence of physiological function in the retina","volume":"5","author":"Militante","year":"2002","journal-title":"Nutr Neurosci"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0069|ane1684-cit-0069","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0014-4835(05)80024-7","article-title":"Lesion topography and new histological features in feline taurine deficiency retinopathy","volume":"61","author":"Leon","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0070|ane1684-cit-0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jnr.490360307","article-title":"Retinal morphology and visual pigment levels in 6- and 12-month-old rhesus monkeys fed a taurine-free human infant formula","volume":"36","author":"Imaki","year":"1993","journal-title":"J Neurosci Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0071|ane1684-cit-0071","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fj.01-0691fje","article-title":"Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice","volume":"16","author":"Heller-Stilb","year":"2002","journal-title":"FASEB J"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0072|ane1684-cit-0072","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-4835(88)80080-0","article-title":"Synergism between environmental lighting and taurine depletion in causing photoreceptor cell degeneration","volume":"46","author":"Rapp","year":"1988","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0073|ane1684-cit-0073","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198501173120302","article-title":"Nutritional requirement for taurine in patients receiving long-term parenteral nutrition","volume":"312","author":"Geggel","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0074|ane1684-cit-0074","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2174\/0929867054546582","article-title":"Taurine analogues; a new class of therapeutics: retrospect and prospects","volume":"12","author":"Gupta","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0075|ane1684-cit-0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ajcn\/52.4.758","article-title":"Taurine concentrations in plasma and whole blood in humans: estimation of error from intra- and interindividual variation and sampling technique","volume":"52","author":"Trautwein","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0076|ane1684-cit-0076","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01636947","article-title":"Plasma and whole blood taurine concentrations respond differently to taurine supplementation (humans) and depletion (cats)","volume":"34","author":"Trautwein","year":"1995","journal-title":"Z Ernahrungswiss"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0077|ane1684-cit-0077","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1079\/BJN19860082","article-title":"Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores","volume":"56","author":"Rana","year":"1986","journal-title":"Br J Nutr"},{"issue":"6 Suppl 1","key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0078|ane1684-cit-0078","doi-asserted-by":"crossref","first-page":"1395S","DOI":"10.1093\/jn\/132.6.1395S","article-title":"Nutrient requirements for preterm infant formulas","volume":"132","author":"Klein","year":"2002","journal-title":"J Nutr"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0079|ane1684-cit-0079","first-page":"78","article-title":"Taurine - monograph","volume":"6","year":"2001","journal-title":"Altern Med Rev"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0080|ane1684-cit-0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, l-glutamine and l-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0081|ane1684-cit-0081","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2004.07.033","article-title":"The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha","volume":"1023","author":"Lee","year":"2004","journal-title":"Brain Res"},{"issue":"2 Pt","key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0082|ane1684-cit-0082","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/bj2830391","article-title":"The gamma-aminobutyric acid transporter and its interaction with taurine in the apical membrane of the bovine retinal pigment epithelium","volume":"283","author":"Sivakami","year":"1992","journal-title":"Biochem J"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0083|ane1684-cit-0083","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mvr.2006.10.003","article-title":"Function and regulation of taurine transport at the inner blood-retinal barrier","volume":"73","author":"Tomi","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0084|ane1684-cit-0084","unstructured":"Shimono KK Azuma J Ikeda T Iwatani Y Kimura SO Temporal changes in plasma taurine level in patients with infantile spasms taking vigabatrin 2011"},{"key":"10.1111\/j.1600-0404.2012.01684.x-BIB1684-bib-0085|ane1684-cit-0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0955-2863(91)90060-I","article-title":"Evaluating taurine status: determination of plasma and whole blood taurine concentration","volume":"2","author":"Trautwein","year":"1991","journal-title":"J Nutr Biochem"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2012.01684.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2012.01684.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:18:02Z","timestamp":1743200282000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2012.01684.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,26]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01684.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,26]]}}}